By week 6, all four hematopoietic stem and progenitor cell (HSPC) compartments were transformed into B-ALL phenotype with CD34− CD19+ and variable CD10 expression (Fig. 7b and Supplementary Fig. 19b), including from originally CD10+ CLPs. This evidence concerns the gene CD19 and acute lymphoblastic leukemia.